🇺🇸 FDA
Pipeline program

Treatment group

W81XWH-19-1-0848

Phase 3 small_molecule completed

Quick answer

Treatment group for Post Operative Surgical Site Infection is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Post Operative Surgical Site Infection
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials